Memorial Sloan-Kettering Cancer Center: Rockefeller Outpatient Pavilion

New York, New York 10022

0 studies enrolling now · 4 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Non-small Cell Lung Cancer, Solid Tumor

Studies at this site

• PF-07284892 in Participants With Advanced Solid Tumors — Stopped early
• A Study Of Dacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung Cancer — Completed
• An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene — Completed
• An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene — Completed